We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BA:NYSEBoeing Company (The) Analysis

Data as of 2026-05-22 - not real-time

$219.61

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock trades just below its short‑term moving average while the medium‑term average sits slightly lower, creating a neutral technical backdrop. Momentum indicators sit in the middle range, with the RSI indicating neither overbought nor oversold conditions. The MACD histogram is firmly negative, signaling bearish momentum in the near term. Volume has been picking up, suggesting that any move could be supported by stronger participation. Volatility remains very high, reflecting the market’s sensitivity to news and earnings swings. Valuation metrics are dramatically above both peers and intrinsic estimates, pointing to a potentially overvalued price.
Fundamentals reveal modest top‑line growth but razor‑thin margins and a negative EBITDA, compounded by an exceptionally high debt load that dwarfs cash on hand. Return ratios are weak, and the company does not pay a dividend, limiting income‑focused appeal. Recent material news includes a sizable new order from China and a strategic partnership on connectivity antennas, both of which could bolster the commercial segment’s outlook. At the same time, competitive pressure from emerging aerospace players and heightened geopolitical scrutiny add to the regulatory and geographic headwinds. Given the blend of technical weakness, valuation stretch, and balance‑sheet strain, short‑term positioning should be cautious while the longer horizon may benefit from the upside catalysts if execution improves. Investors should monitor debt‑reduction progress, order fulfillment, and any policy developments that could affect international sales.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish MACD momentum
  • extreme valuation stretch
  • heavy debt burden

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • new China order pipeline
  • strategic connectivity partnership
  • need for debt reduction

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • long‑term aerospace demand
  • potential balance‑sheet deleveraging
  • valuation correction over time

Key Metrics & Analysis

Financial Health

Revenue Growth14.00%
Profit Margin2.46%
P/E Ratio86.8
ROE169.95%
ROA-2.07%
Debt/Equity828.70
P/B Ratio28.9
Op. Cash Flow$2.5B
Free Cash Flow$2.6B
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI45.3
Support$214.00
Resistance$244.07
MA 20$228.09
MA 50$217.71
MA 200$219.60
MACDBearish
VolumeIncreasing
Fear & Greed Index90.96

Valuation

Fair Value$38.21
Target Price$270.00
Upside/Downside22.95%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.07
Volatility36.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.